Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 2007 2019

Filtrer
Poster
2019

A study in optimizing follow up for postmenopausal women with breast cancer treated with adjuvant endocrine therapy

Lundgaard Riis, C., Bechmann, T., Jensen, P. T., Coulter, A. & Dahl Steffensen, K., 29. aug. 2019.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Blood natural killer cells as a new, independent prognostic factor in recurrent ovarian cancer

Henriksen, J. R., Nederby, L., Donskov, F., Waldstrøm, M., Adimi, P., Jakobsen, A. & Dahl Steffensen, K., 29. aug. 2019.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Development of a decision aid to support ovarian cancer patient decide on CA125 biomarker monitoring

Kargo, A. S., Coulter, A., Jensen, P. T. & Dahl Steffensen, K., 12. apr. 2019.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

HOXA9 methylation as a prognostic marker in platinum-resistant ovarian cancer

Faaborg, L., Henriksen, J. R., Andersen, R. F., Adimi, P., Jakobsen, A. & Dahl Steffensen, K., 29. aug. 2019.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterFormidling

Prognostic Impact of NK-cells, T-cells and PD-L1 in Ovarian Cancer

Henriksen, J. R., Waldstrøm, M., Donskov, F., Jakobsen, A., Hjortkjær, M. & Dahl Steffensen, K., 22. mar. 2019.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Tissue immune response in ovarian cancer

Henriksen, J. R., Donskov, F., Jakobsen, A., Waldstrøm, M., Hjortkjær, M. & Dahl Steffensen, K., 1. jun. 2019.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2018

CABAZITAXEL - A TREATMENT OPTION IN RECURRENT PLATINUM-RESISTANT OVARIAN CANCER

Madsen, C. V., Adimi, P., Jakobsen, A. & Dahl Steffensen, K., 16. sep. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang
37 Downloads (Pure)

DEVELOPMENT OF A PATIENT DECISION AID TEMPLATE FOR USE IN DIFFERENT CLINICAL SETTINGS

Olling, K., Bechmann, T., Madsen, P. H., Hugger Jakobsen, E., Hilberg, O., Coulter, A. & Dahl Steffensen, K., 30. aug. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Fil

Individul survivorship program for ovarian cancer patients based on PROM and shared decision making - PROMova

Kargo, A. S., Coulter, A., Hjøllund, N. H. I., Jensen, P. T. & Dahl Steffensen, K., 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Kan anvendelse af Patient Reported Outcome Measures (PROM) forbedre opfølgningen af ovariecancer patienter? PROMova, et national projekt.

Kargo, A. S., Coulter, A., Hjøllund, N. H. I., Jensen, P. T. & Dahl Steffensen, K., 30. aug. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

Dahl Steffensen, K., Andersen, R. F. & Jakobsen, A., 4. jun. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang

Optimeret opfølgning for brystkræftpatienter i sygehusregi

Christensen, C. L., Bechmann, T., Jensen, P. T., Coulter, A. & Dahl Steffensen, K., 18. jan. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Shared decision making in care for the gynecologic cancer patient

Dahl Steffensen, K., Fokdal, L. U., Ør Knudsen, A., Madsen, C. V., Jensen, P. T., Lundvall, L., Olling, K., Lemley, B., Blou, D., Hanne, B. & Mette, H., 30. aug. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang

Shared decision making in decision on adjuvant radiotherapy for early stage breast cancer patients

Bechmann, T., Ellegaard, M-B. B., Hugger Jakobsen, E., Offersen, B. V., Bøje, C. R., Zachariae, B. & Dahl Steffensen, K., 30. aug. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang

SHARED DECISION MAKING IN THE CARE FOR THE GYNECOLOGIC CANCER PATIENT

Mette, H., Fokdal, L. U., Ør Knudsen, A., Madsen, C. V., Jensen, P. T., Lundvall, L., Olling, K., Lemley, B., Blou, D., Hanne, B. & Dahl Steffensen, K., 15. sep. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang

Validation and incorporation of oncologic and relapse data from Danish National Patient Registry (NPR) in the Danish Gynecological Cancer Database (DGCD)

Weng Ekman-Gade, A., Høgdall, C., Fagö-Olsen, C. L., Dahl Steffensen, K., Hjortkjær, M., Mejer Sørensen, S., Høgdall, E., Jochumsen, K., Antonsen, S. L., Ingerslev, K. H., Kahr, H. S. & Schnack Henriksen, T., 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2017

Individuel survivorship program for ovarian cancer patients based on PROM and shared decision making - PROMova

Kargo, A. S., Coulter, A., Hjøllund, N. H. I., Jensen, P. T. & Dahl Steffensen, K., 2017.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2016
9 Downloads (Pure)

A first step in shared decision making. Developing a decision aid for the choice of anal cancer radiotherapy

Olling, K., Wee, L., Jensen, L. H. & Dahl Steffensen, K., 19. sep. 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang
Fil
12 Downloads (Pure)

A first step in shared decision making – developing a decision aid for the choice of anal cancer radiotherapy.

Olling, K., Wee, L., Jensen, L. H. & Dahl Steffensen, K., 19. sep. 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterFormidling

Fil

Forsøgs- eller standard behandling?

Gregersen, T. A., Ammentorp, J., Birkelund, R., Dahl Steffensen, K. & Wolderslund, M., 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

LBA50 - Influence of concomitant clopidogrel consumption on development of paclitaxel-associated toxicity: A pharmacoepidemiological study

K, A., Mau-Sørensen, M., Stage, T. B., Dahl Steffensen, K., Hallas, J., Brøsen, K. & Bergmann, T. K., 8. okt. 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang

Neutrophils as a prognostic factor in the systemic treatment of Ovarian Cancer

Henriksen, J. R. & Dahl Steffensen, K., 29. okt. 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang

Veliparib monotherapy to patients with BRCA germline mutation and platinum-resistant or partially platinum-sensitive selapse of epithelial ovarian cancer: A phase I/II study

Dahl Steffensen, K., Adimi, P. & Møller Jakobsen, A. K., 6. jun. 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2014

Prognosis of Patients with cervical cancer diagnosed during pregnancy

Halaska, M. J., Uzan, C., Han, S. N., Fruscio, R., Dahl Steffensen, K., Skultety, J., Giuliani, D., Mephon, A., Rouzier, R., Witteveen, P. O., Locatelli, A., Rob, L. & Amant, F., 2014.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

The prognostic value of BRCA1 and PARP expression in epithelial ovarian carcinoma – immunohistochemical detection

Hjortkjær, M., Waldstrøm, M., Kanstrup, H., Søgaard-Andersen, E., Jakobsen, A. & Dahl Steffensen, K., 2014.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2012

Estimation of Immunohistochemical Expression of VEGF in Ductal Carcinomas of the Breast

Bidragets oversatte titel: Estimering af immunhistokemisk expression af VEGF i ductalt carcinomMaae, E., Nielsen, M., Dahl Steffensen, K., Jakobsen, E. H., Jakobsen, A. & Sørensen, F. B., mar. 2012.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Panitumumab nd pegylated liposomal doxirubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: The PaLiDo study, a phase II nonrandomized multicenter study

Dahl Steffensen, K., Waldstrøm, M., Pallisgaard, N., Lund, B., Bergfeldt, K., Wihl, J., Keldsen, N., Marth, C., Vergote, I. & Jakobsen, A., 2012.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang

Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer

Maae, E., Olsen, D. A., Dahl Steffensen, K., Jakobsen, E. H., Brandslund, I., Sørensen, F. B. & Jakobsen, A., apr. 2012.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Quantitative tissue HER2 protein concentration does not expand the group of patients eligible for adjuvant HER2-targeted therapy

Bechmann, T., Olsen, D. A., Jakobsen, E. H., Madsen, J. S., Brandslund, I., Jylling, A. M. B., Dahl Steffensen, K. & Jakobsen, A., 20. apr. 2012.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

The clinical outcome in breast cancer patients with HER2 status determined by a quantitative ELISA technique

Bechmann, T., Jakobsen, E. H., Madsen, J. S., Brandslund, I., Olsen, D. A., Jylling, A. M. B., Dahl Steffensen, K. & Jakobsen, A., 5. maj 2012.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

The prognostic and predictive value of combined HE4 and CA125 in ovarian cancer patients

Dahl Steffensen, K., Waldstrøm, M., Brandslund, I., Petzold, M. & Jakobsen, A., 2012.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang
2011

Mathematical modeling of CA125 kinetics in recurrent ovarian cancer (ROC) patients treated with chemotherapy and predictive value of early modeled kinetic parameters in CALYPSO trial: A GCIG study.

You, B., Colomban, O., Heywood, M., Lee, C., Davy, M., Reed, N., Pignata, S., Fossati, R., Emons, G., Rehman, K. L., Petru, E., Gebski, V., Burges, A., Tubiana-Matthieu, N., Hansen, M., Vasey, P. A., Denison, U., De Bruyne, P. & Oza, A. M., 2011.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang

The clinical significance of quantitative HER2 determination in breast cancer

Bechmann, T., Jakobsen, E. H., Madsen, J. S., Jylling, A. M. B., Dahl Steffensen, K. & Jakobsen, A., 10. mar. 2011.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2010

Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: An ongoing, non-randomized, multicenter, phase II trial

Dahl Steffensen, K., Waldstrøm, M., Lund, B., Bergfeldt, K., Kjeldsen, N., Marth, C., Vergote, I. & Jakobsen, A., 2010.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Platinum
Ovarian Neoplasms
Epidermal Growth Factor Receptor
Neoplasms
Topotecan
2009

Association of ERCC1 protein expression to platinum resistance in epithelial ovarian cancer

Dahl Steffensen, K., Waldstrøm, M. & Jakobsen, A., 2009.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Åben adgang
Platinum
Enzymes
Proteins
Neoplasms
Ovarian Neoplasms

The predictive value of CD44, Myd88 and ERCC1 to the effect of chemotherapy in ovarian cancer

Dahl Steffensen, K., Waldstrøm, M., Visintin, I., Silasi, D. & Jakobsen, A., 2009.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2008

Absence of mutant epidermal growth factor receptor (EGFRVIII) in normal, benign, borderline and malignant ovarian tissue

Dahl Steffensen, K., Waldstrøm, M., Olsen, D. A., Corydon, T., Knudsen, H. J., Jeppesen, U., Brandslund, I. & Jakobsen, A., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Multiplex serum tumor markers for the prediction of early relapse in ovarian cancer patients

Dahl Steffensen, K., Waldstrøm, M., Visintin, I., Brandslund, I. & Jakobsen, A., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 ad HER4 in benign and malignant ovarian tumors

Dahl Steffensen, K., Waldstrøm, M., Andersen, RF., Olsen, DA., Jeppesen, U., Knudsen, HJ., Brandslund, I. & Jakobsen, A., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

The predictive value of CD44, Myd88 and ERCC1 to the effect of chemotherapy in ovarian cancer

Dahl Steffensen, K., Waldstrøm, M., Visintin, I., Silasi, D., Jakobsen, A. & Mor, G., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

The prognostic importance of EGFR and COX-2 expression in advanced cervic cancer

Adimi, P., Schledermann, D., Dahl Steffensen, K. & Jakobsen, A., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review